Literature DB >> 7692601

FMR1 protein: conserved RNP family domains and selective RNA binding.

C T Ashley1, K D Wilkinson, D Reines, S T Warren.   

Abstract

Fragile X syndrome is the result of transcriptional suppression of the gene FMR1 as a result of a trinucleotide repeat expansion mutation. The normal function of the FMR1 protein (FMRP) and the mechanism by which its absence leads to mental retardation are unknown. Ribonucleoprotein particle (RNP) domains were identified within FMRP, and RNA was shown to bind in stoichiometric ratios, which suggests that there are two RNA binding sites per FMRP molecule. FMRP was able to bind to its own message with high affinity (dissociation constant = 5.7 nM) and interacted with approximately 4 percent of human fetal brain messages. The absence of the normal interaction of FMRP with a subset of RNA molecules might result in the pleiotropic phenotype associated with fragile X syndrome.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7692601     DOI: 10.1126/science.7692601

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  255 in total

Review 1.  Candidate RNA-binding proteins regulating extrasomatic mRNA targeting and translation in mammalian neurons.

Authors:  Stefan Kindler; Michaela Monshausen
Journal:  Mol Neurobiol       Date:  2002-04       Impact factor: 5.590

2.  T7 phage display: a novel genetic selection system for cloning RNA-binding proteins from cDNA libraries.

Authors:  S Danner; J G Belasco
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-23       Impact factor: 11.205

3.  A proline-rich protein binds to the localization element of Xenopus Vg1 mRNA and to ligands involved in actin polymerization.

Authors:  W M Zhao; C Jiang; T T Kroll; P W Huber
Journal:  EMBO J       Date:  2001-05-01       Impact factor: 11.598

Review 4.  Networking in autism: leveraging genetic, biomarker and model system findings in the search for new treatments.

Authors:  Jeremy Veenstra-VanderWeele; Randy D Blakely
Journal:  Neuropsychopharmacology       Date:  2011-09-21       Impact factor: 7.853

Review 5.  Local RNA translation at the synapse and in disease.

Authors:  Liqun Liu-Yesucevitz; Gary J Bassell; Aaron D Gitler; Anne C Hart; Eric Klann; Joel D Richter; Stephen T Warren; Benjamin Wolozin
Journal:  J Neurosci       Date:  2011-11-09       Impact factor: 6.167

6.  In vivo association of the stability control protein alphaCP with actively translating mRNAs.

Authors:  Xinjun Ji; Jian Kong; Stephen A Liebhaber
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

Review 7.  Imaging of single mRNAs in the cytoplasm of living cells.

Authors:  Dahlene Fusco; Edouard Bertrand; Robert H Singer
Journal:  Prog Mol Subcell Biol       Date:  2004

8.  Determination and augmentation of RNA sequence specificity of the Nova K-homology domains.

Authors:  Kiran Musunuru; Robert B Darnell
Journal:  Nucleic Acids Res       Date:  2004-09-14       Impact factor: 16.971

Review 9.  Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome.

Authors:  Elizabeth M Berry-Kravis; Lothar Lindemann; Aia E Jønch; George Apostol; Mark F Bear; Randall L Carpenter; Jacqueline N Crawley; Aurore Curie; Vincent Des Portes; Farah Hossain; Fabrizio Gasparini; Baltazar Gomez-Mancilla; David Hessl; Eva Loth; Sebastian H Scharf; Paul P Wang; Florian Von Raison; Randi Hagerman; Will Spooren; Sébastien Jacquemont
Journal:  Nat Rev Drug Discov       Date:  2017-12-08       Impact factor: 84.694

Review 10.  FMR1: a gene with three faces.

Authors:  Ben A Oostra; Rob Willemsen
Journal:  Biochim Biophys Acta       Date:  2009-02-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.